SA receives first batch of new HIV prevention medicine Lenacapavir
The medicine, a six-monthly injectable, is part of the country’s integrated and people-centred HIV prevention strategy, aimed at reducing new infections and sustaining the HIV response in line with the Global AIDS Strate